These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 4262497)

  • 1. [Melanoma of the uvea, cancer of the eye and immune phenomena].
    Vérin P; Gendre P; Meunier J
    Arch Ophtalmol Rev Gen Ophtalmol; 1972; 32():Suppl 1:21-8. PubMed ID: 4262497
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immunologic phenomenon and melanosarcoma of the uvea].
    Verin P; Meunier J; Gendre P; Bergeon JJ; Sekkat A; Morax S
    Arch Ophtalmol Rev Gen Ophtalmol; 1971 Nov; 31(11):781-92. PubMed ID: 4259656
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous delayed hypersensitivity reactions to soluble melanoma antigen in patients with ocular malignant melanoma.
    Char DH; Hollinshead A; Cogan DG; Ballintine EJ; Hogan MJ; Herberman RB
    N Engl J Med; 1974 Aug; 291(6):274-7. PubMed ID: 4407111
    [No Abstract]   [Full Text] [Related]  

  • 4. Alloantigens placed into the anterior chamber of the eye induce specific suppression of delayed-type hypersensitivity but normal cytotoxic T lymphocyte and helper T lymphocyte responses.
    Niederkorn JY; Streilein JW
    J Immunol; 1983 Dec; 131(6):2670-4. PubMed ID: 6196396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pigment tumors of vascular tract of human eye].
    Vit VV
    Oftalmol Zh; 1976; 31(1):57-64. PubMed ID: 828710
    [No Abstract]   [Full Text] [Related]  

  • 6. Tumor-specific immunity in patients with malignant melanoma.
    Arlen M; Hollinshead A; Scherrer J
    Surg Forum; 1977; 28():168-9. PubMed ID: 83008
    [No Abstract]   [Full Text] [Related]  

  • 7. [Distribution of the HLA antigen system in melanoblastoma of the uvea].
    Ignatov RK; Terent'eva LS; Shul'gina NS
    Oftalmol Zh; 1977; 32(4):289-94. PubMed ID: 896116
    [No Abstract]   [Full Text] [Related]  

  • 8. Delayed cutaneous hypersensitivity reactions to extracts of breast cancer and melanoma tissue in cancer patients.
    Fossati G; Canevari S; Pierotti MA; Vezzoni P; Porta GD; Vaglini M
    J Natl Cancer Inst; 1979 Jun; 62(6):1381-5. PubMed ID: 286110
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical course, prognosis and therapy of malignant uveal melanoma].
    Benthien H
    Klin Monbl Augenheilkd; 1968; 153(1):4-16. PubMed ID: 4876279
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular resistance to human uveal melanoma. An in vitro study.
    Hart DR; Reznikov M; Hughes LE
    Arch Ophthalmol; 1968 Jun; 79(6):748-54. PubMed ID: 5652266
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunological studies in intraocular tumors].
    Kotelianskiĭ EO
    Oftalmol Zh; 1982; 37(1):54-8. PubMed ID: 7043350
    [No Abstract]   [Full Text] [Related]  

  • 12. Melanoma antigens that produce cell-mediated immune responses in melanoma patients: joint U.S.-U.S.S.R. study.
    Gorodilova VV; Hollinshead A
    Science; 1975 Oct; 190(4212):391-2. PubMed ID: 1179218
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunofluorescent detection of antibodies to ocular melanomas.
    Wong IG; Oskvig RM
    Arch Ophthalmol; 1974 Aug; 92(2):98-102. PubMed ID: 4136249
    [No Abstract]   [Full Text] [Related]  

  • 14. Prospects for the immunodiagnosis of ocular tumours.
    Garner A; Rahi AH
    Trans Ophthalmol Soc U K (1962); 1979 Apr; 99(1):150-5. PubMed ID: 398603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Case of multiple malignant neoplasms: bronchial carcinoma and melanoma of the uvea].
    Szczepaniec M; Maciejewski Z; Pietoń R
    Gruzlica; 1975 Jan; 43(1):73-5. PubMed ID: 1110041
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological studies in patients with malignant melanoma of the uvea.
    Brownstein S; Sheikh KM; Lewis MG
    Can J Ophthalmol; 1977 Jan; 12(1):16-23. PubMed ID: 849536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of melanoma].
    Hofmann H
    Klin Monbl Augenheilkd; 1969 Apr; 154(4):552-5. PubMed ID: 5357964
    [No Abstract]   [Full Text] [Related]  

  • 18. Lymphoproliferative response as an index of cellular immunity in malignant melanoma of the uvea and its correlation with the histological features of the tumour.
    Sunba MS; Rahi AH; Morgan G; Holborow EJ
    Br J Ophthalmol; 1980 Aug; 64(8):576-90. PubMed ID: 7426575
    [No Abstract]   [Full Text] [Related]  

  • 19. [Immunochemistry in ophthalmo-oncology: problems and prospects].
    Iurovskaia NN; Suchkov SV
    Vestn Oftalmol; 1983; (3):70-2. PubMed ID: 6349090
    [No Abstract]   [Full Text] [Related]  

  • 20. Study of autoimmune serologic reactions to ocular melanoma.
    Howard GM; Spalter HF
    Arch Ophthalmol; 1966 Sep; 76(3):399-402. PubMed ID: 4957740
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.